Alligo

Alligo

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Alligo - Softer growth, but margin recovery continues

08 juli 2026

  • We see 1% organic growth in Q2 as the winter weather boost fades
  • Cost savings and FX lift adj. EBITA margin 1.4pp y-o-y to 7.2%
  • New CEO Samuel Alteborg took over the helm on 1 June

Q2 expectations

The strong Q1 organic growth of 5% was boosted by cold winter weather, which naturally did not recur in Q2. With underlying demand stable q-o-q, we forecast organic growth of 1%, with FX and bolt-on M&A lifting total growth to around 4%. The positive gross margin trend should persist, driven by own-brand sales and favourable FX, and we forecast 41.5% (40.1%). Together with the final quarter of benefit from the H2'25 cost savings, this takes the adj. EBITA margin to 7.2% (5.8%). We expect the Finland restructuring to continue, but at a lower one-off cost than in Q1, at around SEK -4m.

Estimate changes

We make only very minor changes, leaving our '26e-'28e estimates broadly unchanged. Sweden continues to develop well, while the Finland restructuring keeps weighing somewhat on the near-term results, albeit with lower one-off costs in Q2 than in Q1.

Outlook and valuation

Samuel Alteborg took over as CEO on 1 June, having previously led rental company Cramo, and we look forward to hearing his strategy for Alligo after the summer. Our early impression is that his experience is highly relevant and that near-term continuity is intact. Our overall view is unchanged: Alligo should reap the rewards of an improving market over the coming years, with organic growth driving further margin recovery and, in turn, substantial adj. EPS growth of around 25% in '26e. The share is trading at a '26e-'28e P/E of 12-9x, and we reiterate our fair value range of SEK 120-190.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-15 Infrea - Strong quarter but pegged to Netel Infrea Analys
2026-07-15 Coor - Solid earnings despite softer sales Coor Analys
2026-07-15 Svedbergs Group - Nordics and one-offs weigh Svedbergs G.. Analys
2026-07-14 Nexam Chemical - Solid Q2, profitability within r... Nexam Chemical Analys
2026-07-14 Nexam Chemical - Record sales and first positive ... Nexam Chemical Analys
2026-07-14 Eastnine - Warsaw to become the largest market Eastnine Analys
2026-07-13 Ascelia Pharma - CRL update Ascelia Pharma Analys
2026-07-13 Medicover - Steady as she goes Medicover Analys
2026-07-13 Arctic Paper - Pulp beats paper Arctic Paper Analys
2026-07-13 Studsvik - Gearing up for the new-build era Studsvik Analys
2026-07-10 StrongPoint - The American dream StrongPoint Analys
2026-07-10 Careium - The pressure valve starting to open Careium Analys
2026-07-10 StrongPoint - Solid Q2 performance StrongPoint Analys
2026-07-10 Careium - Growth's comeback tour continues Careium Analys
2026-07-09 Infrea - Road tripping with Netel Infrea Analys
2026-07-08 Alligo - Softer growth, but margin recovery conti... Alligo Analys
2026-07-08 Qliro - Key earnings drivers intact Qliro Analys
2026-07-07 Nexam Chemical - We expect a firmer sequential qu... Nexam Chemical Analys
2026-07-07 Eastnine - Adding in Warsaw Eastnine Analys
2026-07-06 Ovzon - No Q2 fireworks, but plenty of fuel Ovzon Analys